AnaveonListed
No domain yetbiotech_life_sciences
Anaveon is a late stage preclinical biotech company focused on developing engineered antibodies that target central regulatory nodes of the immune system to treat autoimmune disea…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Anaveon is a late stage preclinical biotech company focused on developing engineered antibodies that target central regulatory nodes of the immune system to treat autoimmune disea…
Aquinnah Pharmaceuticals is a biotechnology company focused on developing treatments for neurodegenerative diseases such as Alzheimer's and ALS. The company specializes in creatin…
Arrakis Therapeutics is pioneering a new class of genetic medicines known as RNA-targeted small molecules (rSMs), aiming to unlock new biology for patients by creating oral medici…
Artios Pharma is focused on developing innovative therapies for cancer treatment through its proprietary DNA Damage Response (DDR) platform.
Autifony Therapeutics is a clinical-stage biotech company focused on developing treatments for rare genetic CNS disorders and hearing disorders.
Autobahn Therapeutics is focused on developing next-generation regenerative medicines for central nervous system (CNS) disorders, utilizing a brain-targeting chemistry platform to…
Preclinical stage biotech company advancing next-generation B-cell therapies for autoimmune diseases.
Details are not available yet. The company remains listed.
DEM Biopharma is a privately held, Cambridge, MA based pre-IND stage biopharmaceutical company dedicated to discovering novel therapeutic targets for solid tumors. Our innovative…
Enodia Therapeutics is a biotechnology company developing small-molecule therapies that selectively degrade disease-driving proteins at the point of synthesis, focusing on immuno-…
EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell…
FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.
Greywolf Therapeutics is focused on developing novel antigen modulation treatments to guide the immune system, particularly for cancers and autoimmune disorders. Their approach ai…
Immunocodex is committed to finding novel breakthroughs for the treatment of autoimmune diseases through innovative lipid nanoparticle mRNA-based therapies designed to induce anti…
ImmunOs Therapeutics AG is dedicated to developing novel therapeutics that harness the immune system to treat cancer and inflammatory diseases. Their approach is based on identify…
Incendia Therapeutics is a clinical-stage biotechnology company discovering and developing novel monoclonal antibody therapies that disrupt the tumor microenvironment (TME) to imp…
Kestrel Therapeutics focuses on developing therapies targeting KRAS mutations in cancer, aiming to exploit oncogene addiction for effective drug development.
Levicept is a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for knee osteoarthritis, targeting neurotrophin pathways to provide pain reli…
Mediar Therapeutics is pioneering a novel approach to fibrosis treatment by disabling the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progress…
MindImmune Therapeutics Inc. is a drug discovery company pioneering a new approach to treat Alzheimer’s disease and other neuro-degenerative conditions by targeting the immune dri…
Mission Therapeutics is a drug development company focused on treating kidney disease, neurodegenerative diseases, and rare mitochondrial diseases. The company targets the ubiquit…
Montis Biosciences is a preclinical-stage biopharmaceutical company advancing innovative therapeutics to treat inflammation-driven autoimmune disorders and neurodegenerative disea…
Mozart Therapeutics is a clinical-stage biopharmaceutical company committed to developing disease-modifying therapies that restore healthy immune system function in patients with…
National Resilience, Inc. is a technology-driven biomanufacturing company focused on advancing the development and production of complex medicines to improve global health. The co…
Nimbus Therapeutics is focused on developing breakthrough medicines through precision small molecule design, emphasizing selectivity in drug discovery and clinical development.
Normunity is a biotechnology company creating novel anti-cancer therapies that address untapped biology at the interface of the immune system and the tumor to target mechanisms th…
Nucleome Therapeutics is a biotechnology company using 3D genomics to discover precision medicines for complex diseases, particularly focusing on inflammatory conditions. Their pr…
Oblenio Bio aims to transform the treatment of refractory autoimmune diseases through innovative therapies, specifically focusing on their tri-specific T-cell engager, LBL-051, de…
OTR Therapeutics is a biotechnology company focused on developing innovative treatments for critical diseases, with a strategic focus on oncology, immunology and inflammation, and…
Palleon Pharmaceuticals is a clinical-stage company pioneering drug development in glyco-immunology, focusing on autoimmune and cancer medicines through glycobiology.
PrescriberPoint is a healthcare technology company that provides resources to help healthcare providers prescribe medications efficiently. It offers a digital ecosystem where heal…
ReCode Therapeutics is developing therapeutics for genetically defined diseases with no existing treatment options, including cystic fibrosis and primary ciliary dyskinesia, using…
RefleXion Medical is an external beam theranostic oncology company that has developed SCINTIX® autonomous radiotherapy, which utilizes signals emitted from cancer cells to deliver…
Saama develops life science solutions that accelerate the delivery of therapies to patients. With innovative AI technologies, Saama drives breakthrough intelligence into clinical…
STORM Therapeutics is a clinical biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. Their lead product…
Strata Oncology is a precision oncology company focused on delivering optimal cancer treatments through molecular profiling and clinical trials. It develops biomarkers like Immuno…
TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biolo…
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel therapeutics to treat diseases. The company focus…
TRIMTECH Therapeutics is a biotechnology company that is developing a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic prote…
Vibrant Therapeutics develops conditional activation and targeted delivery multispecific antibody-based prodrugs, focusing on life-saving biotherapeutics for oncological, autoimmu…
Flare Therapeutics is focused on developing small molecule medicines that target transcription factors to treat diseases, particularly in precision oncology. Their pipeline includ…
Crossbow Therapeutics, Inc. is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimeti…
Enlaza is developing first-in-class covalent protein therapeutics to transform the treatment of cancer and other serious diseases. Their proprietary War-Lock technology enables th…
Curve Therapeutics is a private biotechnology company pioneering a revolutionary intracellular screening platform to enable the discovery of innovative therapeutics that address c…
Enara Bio is shining a light on Dark Antigen and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients w…